Municipalities and States Grapple with Rising Health-Insurance Costs and Upcoming Medicaid Drug Pricing Deadline

Municipalities across the country are reporting that the cost of providing health insurance to their employees is becoming increasingly unsustainable, putting pressure on local budgets.

States are now facing a critical decision before a September 30 deadline: whether to join a federal program that would grant them "most‑favored nation" drug prices for Medicaid beneficiaries. Participation could lower drug spending but requires states to meet certain eligibility criteria.

The outcome of these choices could reshape Medicaid drug pricing dynamics, affecting both government health‑care expenditures and pharmaceutical revenue streams.